Earlier engagement across global markets
The model was rolled out across multiple affiliates worldwide. Teams were better aligned, stakeholder relationships grew stronger, and market entry was better coordinated.
We help pharma and biotech teams build the evidence, make the call and carry it through to launch. Every project is led by people who have done the job inside the industry.







Studies, systematic reviews and real-world evidence, taken through to publication.
A clear view of an asset's value before you license, buy or invest.
Launch plans that work in real clinics and real markets.
Help deciding which assets to back, and which to stop.
The route to approval and access, including Brazil and Latin America.
Partnerships that turn research into development.
The model was rolled out across multiple affiliates worldwide. Teams were better aligned, stakeholder relationships grew stronger, and market entry was better coordinated.
The team had a clear, practical evidence plan. It sharpened the scientific story, supported talks with payers and improved readiness for a global launch.
The client made informed go/no-go decisions. The work supported regulatory success and found new ways to reposition and differentiate products.

Mauricio Silva de Lima, M.D., Ph.D., founded Pulsus after a career in academic research and senior pharma leadership. He led medical affairs at Genentech, was Medical Director for Eli Lilly in Brazil and the UK, and held global roles at Roche and Takeda. He has written more than 100 peer-reviewed papers and scientific presentations.
You work with him and his partners directly. There is no junior team behind the pitch.
“I was impressed with the breadth of Mauricio’s therapy area knowledge and expertise, from oncology to neuroscience and beyond.”
“A strategic thinker with a proven record of success who … understands medical affairs exceptionally well.”
“He is laser focused on producing extraordinary results.”
Silva de Lima M, Coelho FMS, de Lima HA, de Souza D, Fernandes M, Lourenço JD, do Prado-Lima P
Sleep Medicine 147:109116, 2026
Silva de Lima M, da Silva AG
Journal of Psychopharmacology 39(8):883–885, 2025
Initial discussions are confidential and without obligation. Send a short note and we will reply.